//=time() ?>
Now online @jclinicalinvest A Tumor-intrinsic PD-L1-NLRP3 Inflammasome Signaling Pathway Drives Resistance to Anti-PD-1 Immunotherapy from https://t.co/TR6vFMLakU
Time for a tweetorial! (from ND, BT, and BH) 1/n
https://t.co/QNwhNusIDM